Q13627 (DYR1A_HUMAN) Homo sapiens (Human)

Dual specificity tyrosine-phosphorylation-regulated kinase 1A UniProtKBInterProSTRINGInteractive Modelling

763 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5); 8 identical sequences: Equus caballus: A0A3Q2IAQ6; Pongo abelii: A0A2J8UAI1; Pan troglodytes: H2QL08, A0A6D2WLE2; Camelus ferus: A0A8B8RZL9; Microcebus murinus: A0A8C5VDN6; Vicugna pacos: A0A6I9I9S6; Pteropus vampyrus: A0A6P3QPJ4

Available Structures

76 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human Dual-Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A in complex with a consensus sub… Heteromer
Q5IJ48;
136-480
D15;CL;
Assess
Crystal structure of human DYRK1A in complex with compound 14monomer134-483
SO4;9OF;PGE;
Assess
Human DYRK1A in complex with Leucettine L41monomer132-481
3RA;
Assess
Crystal Structure of DYRK1A with small molecule inhibitormonomer134-482
SO4;EDO;KQK;
Assess
Crystal structure of DYRK1A complexed with FC162 inhibitormonomer134-482
SO4;PG4;DMS;JHW;
Assess
Crystal structure of DYRK1A with harmine-derivatized AnnH-75 inhibitormonomer134-482
PG4;4H5;
Assess
DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.monomer131-479
Q8J;
Assess
Crystal structure of DYRK1A in complex with 10-Chloro-substituted 11H-indolo[3,2-c]quinolone-6-carb…monomer134-481
SO4; 12×EDO;4E2;IOD;
Assess
Crystal structure of DYRK1AA in complex with 10-Bromo-substituted 11H-indolo[3,2-c]quinolone-6-carb…monomer134-481
SO4;EDO;4E3;
Assess
DYRK1A in complex with hydroxy benzothiazole fragmentmonomer134-481
QIV;
Assess
Crystal structure of DYRK1A in complex with RD0392monomer134-481
4VZ;GOL;
Assess
human DYRK1A/inhibitor complexmonomer134-481
EHB;
Assess
human DYRK1A/harmine complexmonomer134-481
HRM;
Assess
Crystal structure of DYRK1A in complex with RD0448monomer134-481
4WD;
Assess
Human DYRK1A in complex with LDN-211898monomer134-481
AWR;PO4;
Assess
Crystal Structure of DYRK1A with small molecule inhibitormonomer135-481
SO4;KQW;
Assess
Crystal Structure of DYRK1A with small molecule inhibitormonomer135-481
SO4;KRQ;EDO;
Assess
Crystal Structure of DYRK1A with small molecule inhibitormonomer134-480
KRK;EDO;DMS;SO4;
Assess
Crystal structure of the human DYRK1A kinase domain bound to abemaciclibmonomer134-480
FLC;6ZV;EDO;PEG;LI;
Assess
DYRK1A IN COMPLEX WITH NITRILE BENZOTHIAZOLE FRAGMENTmonomer134-480
AJG;
Assess
Crystal structure of human DYRK1A in complex with compound 32monomer134-480
9OL;
Assess
DYRK1A in complex with XMD7-117monomer134-480
B5T;
Assess
DYRK1A in complex with XMD14-124monomer134-480
B6Z;
Assess
DYRK1A in complex with JWC-055monomer134-480
B6N;
Assess
DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENTmonomer134-480
Y3L;
Assess
Crystal Structure of DYRK1A with small molecule inhibitormonomer135-481
SO4;PG4;KR8;
Assess
Crystal structure of human DYRK1A in complex with ARN25068monomer135-481
39I;
Assess
Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1Amonomer135-481
D15;CL;P6G;SO4;
Assess
DYRK1A in complex with XMD15-27-2monomer134-480
B6H;
Assess
DYRK1A in complex with HG-8-60-1monomer134-480
B5Z;
Assess
Crystal Structure of DYRK1A with small molecule inhibitormonomer134-480
CL;KQE;
Assess
DYRK1A in complex with XMD8-49monomer134-480
B6B;
Assess
DYRK1A in complex with XMD8-62emonomer134-480
B7B;
Assess
Crystal structure of DYRK1A in complex with 10-Iodo-substituted 11H-indolo[3,2-c]quinoline-6-carbox…monomer135-481
PG4;SO4;4E1;
Assess
Human DYRK1A in complex with PKC412monomer134-480
2K2;
Assess
DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENTmonomer134-480
5PW;
Assess
DYRK1A in complex with JWD-065monomer134-480
B6Q;
Assess
DYRK1A in complex with methoxy benzothiazole fragmentmonomer134-480
7QQ;
Assess
DYRK1A IN COMPLEX WITH FLUORO BENZOTHIAZOLE FRAGMENTmonomer134-480
ZC3;
Assess
Crystal structure of DYRK1A complexed with KuFal319 (compound 11)monomer135-481
PG4;SO4;MLW;
Assess
DYRK1A in complex with XMD7-112monomer134-480
B7W;
Assess
DYRK1A bound to a harmine derivativemonomer135-481
QKG;PG4;
Assess
DYRK1A with PST001monomer134-480
OPW;
Assess
Crystal Structure of DYRK1A with small molecule inhibitormonomer135-480
SO4;KQZ;EDO;
Assess
Structure of DYRK1A in complex with AMPNPmonomer136-481
ANP;
Assess
Structure of DYRK1A in complex with compound 8monomer136-481
QZ2;
Assess
The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitormonomer135-480
2C3;1PE;SO4;
Assess
Structure of DYRK1A in complex with complex 10monomer136-481
MFR;
Assess
A natural inhibitor of DYRK1A for treatment of diabetes mellitusmonomer135-480
EKU;
Assess
Structure of DYRK1A in complex with compound 3monomer136-481
QYH;
Assess
The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitormonomer136-481
2C4;1PE;SO4;
Assess
Structure of DYRK1A in complex with compound 16monomer148-481
CL;QYW;
Assess
Structure of DYRK1A in complex with compound 54monomer148-481
RK2;DMS;
Assess
Structure of DYRK1A in complex with compound 4monomer148-481
6SD;
Assess
Structure of DYRK1A in complex with compound 5monomer148-481
QYK;
Assess
Structure of DYRK1A in complex with compound 50monomer148-481
RK5;CL;
Assess
Structure of DYRK1A in complex with compound 25monomer148-481
RJ8;CL;
Assess
Structure of DYRK1A in complex with compound 38monomer148-481
RKK;CL;
Assess
Structure of DYRK1A in complex with compound 3monomer148-481
RJ5;CL;
Assess
Structure of DYRK1A in complex with compound 53monomer148-481
RHH;PO4;DMS;
Assess
tructure of DYRK1A in complex with compound 24monomer148-481
QZW;CL;
Assess
Structure of DYRK1A in complex with compound 51monomer148-481
RKZ;CL;
Assess
Structure of DYRK1A in complex with compound 28monomer148-481
RJ2;CL;
Assess
Structure of DYRK1A in complex with compound 7monomer148-481
QYZ;
Assess
Structure of DYRK1A in complex with compound 58monomer148-481
RK8;
Assess
Structure of DYRK1A in complex with compound 34monomer148-481
R05;CL;
Assess
Structure of DYRK1A in complex with compound 56monomer148-481
RJZ;
Assess
Structure of DYRK1A in complex with compound 10monomer149-481
RHW;CL;
Assess
Structure of DYRK1A in complex with compound 5monomer149-481
RHZ;CL;
Assess
Structure of DYRK1A in complex with compound 46monomer149-481
RKQ;CL;
Assess
Structure of DYRK1A in complex with compound 16monomer149-481
RHT;CL;
Assess
Structure of DYRK1A in complex with compound 2monomer149-481
QYE;
Assess
Structure of DYRK1A in complex with compound 1monomer148-479
QY8;DMS;
Assess
Structure of DYRK1A in complex with compound 6monomer148-479
QYB;PO4;
Assess
Structure of DYRK1A in complex with compound 33monomer148-479
RKH;GOL;
Assess
Structure of DYRK1A in complex with compound 32monomer148-479
RKW;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3anq.1.Amonomer0.84134-481
EHB;100.00
Assess
7lgs.3.Amonomer0.50149-456
16.83
Assess

7 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23anq.1.Amonomer0.84125-472
EHB;100.00
Assess
Isoform 27lgs.3.Amonomer0.50140-447
16.83
Assess
Isoform 33anq.1.Amonomer0.86134-481
EHB;100.00
Assess
Isoform 37lgs.3.Amonomer0.50150-456
16.83
Assess
Isoform 43anq.1.Amonomer0.86134-481
EHB;100.00
Assess
Isoform 53anq.1.Amonomer0.86134-481
EHB;100.00
Assess
Isoform 57lgs.3.Amonomer0.51150-456
16.78
Assess